• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Alkermes Plc (NQ: ALKS )

    27.53 +0.36 (+1.32%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,117,300
    Open 27.27
    Bid (Size) 26.65 (1)
    Ask (Size) 28.43 (1)
    Prev. Close 27.17
    Today's Range 27.12 - 27.93
    52wk Range 22.01 - 32.88
    Shares Outstanding 166,121,384
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
    Via Benzinga
    NASDAQ:ALKS: good value for what you're paying.
    For those who appreciate value investing, ALKERMES PLC (NASDAQ:ALKS) is a compelling option with its solid fundamentals. 
    Via Chartmill

    Performance

    YTD
    -3.81%
    -3.81%
    1 Month
    -2.34%
    -2.34%
    3 Month
    +13.34%
    +13.34%
    6 Month
    +1.70%
    +1.70%
    1 Year
    -3.61%
    -3.61%

    More News

    Read More
    Despite its impressive fundamentals, NASDAQ:ALKS remains undervalued.
    Via Chartmill
    NASDAQ:ALKS stands out as a stock that provides good value for the fundamentals it showcases.
    Via Chartmill
    ALKS Stock Earnings: Alkermes Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    6 Analysts Assess Alkermes: What You Need To Know
    Via Benzinga
    The Analyst Landscape: 7 Takes On Alkermes
    Via Benzinga
    Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    "Rule Breaker Investing" Stock Pick Review: The Big One
    Via The Motley Fool
    6 Analysts Assess Alkermes: What You Need To Know
    Via Benzinga
    7 Analysts Assess Alkermes: What You Need To Know
    Via Benzinga
    NASDAQ:ALKS is an undervalued gem with solid fundamentals.
    Via Chartmill
    When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
    Via Chartmill
    In a market where value is scarce, NASDAQ:ALKS offers a refreshing opportunity with its solid fundamentals.
    Via Chartmill
    3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
    Via InvestorPlace
    Investors should take notice of NASDAQ:ALKS—it offers a great deal for the fundamentals it presents.
    Via Chartmill
    Exploring growth characteristics of ALKERMES PLC (NASDAQ:ALKS).
    Via Chartmill
    Exploring growth characteristics of ALKERMES PLC (NASDAQ:ALKS).
    Via Chartmill
    Breaking Down Alkermes: 5 Analysts Share Their Views
    Via Benzinga
    Is NASDAQ:ALKS suited for growth investing?
    Via Chartmill
    ALKS Stock Earnings: Alkermes Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Investors should take notice of NASDAQ:ALKS—it offers a great deal for the fundamentals it presents.
    Via Chartmill
    Alkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says
    Via Benzinga
    When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
    Via Chartmill
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.